Maxim Group Raises Gilead Sciences (GILD) Price Target to $97

April 22, 2013 2:46 PM EDT Send to a Friend
Maxim Group today maintained a Buy rating on Gilead Sciences (NASDAQ: GILD) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login